- Home
- NOM vs CASI Comparison
NOM vs CASI Comparison
Compare NOM & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOM
- CASI
- Stock Information
- Founded
- NOM 1993
- CASI 1991
- Country
- NOM United States
- CASI China
- Employees
- NOM N/A
- CASI N/A
- Industry
- NOM Investment Managers
- CASI Biotechnology: Pharmaceutical Preparations
- Sector
- NOM Finance
- CASI Health Care
- Exchange
- NOM Nasdaq
- CASI Nasdaq
- Market Cap
- NOM 25.0M
- CASI 20.5M
- IPO Year
- NOM N/A
- CASI 1996
- Fundamental
- Price
- NOM $10.30
- CASI $1.30
- Analyst Decision
- NOM
- CASI Strong Buy
- Analyst Count
- NOM 0
- CASI 1
- Target Price
- NOM N/A
- CASI $4.00
- AVG Volume (30 Days)
- NOM 6.9K
- CASI 308.6K
- Earning Date
- NOM 01-01-0001
- CASI 08-15-2025
- Dividend Yield
- NOM 3.39%
- CASI N/A
- EPS Growth
- NOM N/A
- CASI N/A
- EPS
- NOM N/A
- CASI N/A
- Revenue
- NOM N/A
- CASI $31,368,000.00
- Revenue This Year
- NOM N/A
- CASI N/A
- Revenue Next Year
- NOM N/A
- CASI N/A
- P/E Ratio
- NOM N/A
- CASI N/A
- Revenue Growth
- NOM N/A
- CASI 8.39
- 52 Week Low
- NOM $8.52
- CASI $1.09
- 52 Week High
- NOM $10.48
- CASI $7.67
- Technical
- Relative Strength Index (RSI)
- NOM 43.02
- CASI 38.95
- Support Level
- NOM $10.32
- CASI $1.09
- Resistance Level
- NOM $10.37
- CASI $1.50
- Average True Range (ATR)
- NOM 0.06
- CASI 0.31
- MACD
- NOM -0.01
- CASI -0.00
- Stochastic Oscillator
- NOM 30.56
- CASI 13.39
About NOM Nuveen Missouri Quality Municipal Income Fund
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in United States. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Missouri state income taxes; its secondary investment objective is the enhancement of portfolio value. The fund invests in municipal securities as well as floating rate securities as well as derivatives such as futures, options and swap contracts to the necessary extent. Nuveen Fund Advisors, LLC acts as an investment adviser of the company.
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.